News US government agency to investigate FDA over rofecoxib BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7472.935 (Published 21 October 2004) Cite this as: BMJ 2004;329:935 Article Related content Metrics Responses Peer review Related articles Editor's Choice Transparency and trust Published: 21 October 2004; BMJ 329 doi:10.1136/bmj.329.7472.0-g See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362